Who owns Kyverna Therapeutics, Inc.?
- Ticker: KYTX
- CUSIP Number: 501976104
Tip: Access positions for across all investors
Analyze quarterly positions in Kyverna Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kyverna Therapeutics stock
Who bought or sold Kyverna Therapeutics, Inc. this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vida Ventures Advisors | 4.5M | $27M | 0% | Sep 2025 |
|
| Gilead Sciences | 4.1M | $25M | 0% | Sep 2025 |
|
| Bain Capital Life Sciences Investors | 3.4M | $20M | 0% | Sep 2025 |
|
| Vanguard Group | 1.3M | $7.9M | 1% | Sep 2025 |
|
| Insight Holdings | 989k | $5.9M | 0% | Sep 2025 |
|
| Franklin Resources | 678k | $4.1M | -3% | Sep 2025 |
|
| Mbb Public Markets I | 615k | $3.7M | 0% | Sep 2025 |
|
| Catalio Capital Management | 587k | $3.5M | 100% | Sep 2025 |
|
| Millennium Management | 552k | $3.3M | 22% | Sep 2025 |
|
| BlackRock | 482k | $2.9M | -10% | Sep 2025 |
|
| Kera Capital Partners | 422k | $2.5M | 0% | Sep 2025 |
|
| Peapod Lane Capital | 319k | $1.9M | -20% | Sep 2025 |
|
| Geode Capital Management | 278k | $1.7M | -3% | Sep 2025 |
|
| Woodline Partners | 252k | $1.5M | 100% | Sep 2025 |
|
| Susquehanna International | 250k | $1.5M | 147% | Sep 2025 |
|
| Jane Street | 214k | $1.3M | 144% | Sep 2025 |
|
| Morgan Stanley | 202k | $620k | 100% | Jun 2025 |
|
| Bridgeway Capital Management | 175k | $1.0M | 178% | Sep 2025 |
|
| TD Asset Management | 165k | $989k | -35% | Sep 2025 |
|
| Renaissance Technologies | 165k | $988k | 34% | Sep 2025 |
|
| UBS Group | 157k | $945k | 60% | Sep 2025 |
|
| Jacobs Levy Equity Management | 148k | $886k | 100% | Sep 2025 |
|
| Two Sigma Investments | 133k | $795k | 10% | Sep 2025 |
|
| Charles Schwab Investment Management | 126k | $754k | 6% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 104k | $623k | -12% | Sep 2025 |
|
| State Street Corporation | 91k | $548k | 0% | Sep 2025 |
|
| Citadel Advisors | 85k | $512k | -77% | Sep 2025 |
|
| Two Sigma Advisers | 81k | $488k | -14% | Sep 2025 |
|
| Barclays | 76k | $457k | 51% | Sep 2025 |
|
| Northern Trust | 52k | $310k | 0% | Sep 2025 |
|
| XTX Topco | 49k | $295k | 41% | Sep 2025 |
|
| Goldman Sachs Group | 43k | $259k | -59% | Sep 2025 |
|
| Stifel Financial | 39k | $233k | 0% | Sep 2025 |
|
| Qube Research & Technologies | 37k | $220k | 161% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 34k | $204k | 668% | Sep 2025 |
|
| American Century Companies | 32k | $193k | 100% | Sep 2025 |
|
| Point72 Asset Management | 27k | $163k | -51% | Sep 2025 |
|
| Caxton | 23k | $138k | 0% | Sep 2025 |
|
| Cubist Systematic Strategies | 20k | $123k | -86% | Sep 2025 |
|
| Springbok Capital Management | 19k | $117k | -46% | Sep 2025 |
|
| JustInvest | 19k | $113k | -1% | Sep 2025 |
|
| Wells Fargo & Company | 18k | $110k | 449% | Sep 2025 |
|
| Leucadia National Corporation | 16k | $98k | 100% | Sep 2025 |
|
| Ethic | 15k | $92k | -10% | Sep 2025 |
|
| Federated Investors | 15k | $91k | -66% | Sep 2025 |
|
| Trexquant Investment | 15k | $91k | 100% | Sep 2025 |
|
| AQR Capital Management | 14k | $81k | -86% | Sep 2025 |
|
| Ameriprise Financial | 13k | $77k | 100% | Sep 2025 |
|
| Point72 Asia | 11k | $65k | -10% | Sep 2025 |
|
| Phoenix Wealth Advisors | 11k | $63k | 0% | Sep 2025 |
|
| Capital Advisors | 10k | $60k | 100% | Sep 2025 |
|
| FMR | 7.9k | $48k | -3% | Sep 2025 |
|
| China Universal Asset Management | 7.6k | $46k | -13% | Sep 2025 |
|
| DekaBank Deutsche Girozentrale | 7.5k | $195k | 0% | Sep 2025 |
|
| Jpmorgan Chase & Co | 6.7k | $40k | -83% | Sep 2025 |
|
| Tower Research Capital | 6.2k | $37k | -43% | Sep 2025 |
|
| Ohio Pers | 4.6k | $28k | 100% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 3.9k | $24k | 0% | Sep 2025 |
|
| Advisor Group Holdings | 2.5k | $15k | 0% | Sep 2025 |
|
| Royal Bank of Canada | 2.0k | $0 | 115% | Sep 2025 |
|
| Mirae Asset Global Investments | 1.7k | $10k | 0% | Sep 2025 |
|
| Pnc Financial Services | 1.7k | $10k | -14% | Sep 2025 |
|
| Russell Investments | 1.3k | $7.9k | 0% | Sep 2025 |
|
| Gf Fund Management | 898.00 | $5.4k | -16% | Sep 2025 |
|
| CWM | 499.00 | $3.0k | -94% | Sep 2025 |
|
| NISA Investment Advisors | 301.00 | $1.8k | 0% | Sep 2025 |
|
| Fourth Dimension Wealth | 250.00 | $1.5k | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 200.00 | $1.2k | 38% | Sep 2025 |
|
| SBI Securities | 137.00 | $822.000000 | -14% | Sep 2025 |
|
| Advisory Services Network | 86.00 | $516.000000 | 100% | Sep 2025 |
|
| IFP Advisors | 16.00 | $96.000000 | 0% | Sep 2025 |
|
| SRS Capital Advisors | 11.00 | $66.000000 | 100% | Sep 2025 |
|
Who sold out of Kyverna Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Superstring Capital Management | Jun 2025 | 143k | $438k |
| Marshall Wace | Jun 2025 | 62k | $191k |
| Y-Intercept | Jun 2025 | 42k | $129k |
| Squarepoint Ops | Jun 2025 | 30k | $91k |
| Jain Global | Jun 2025 | 26k | $81k |
| Hrt Financial | Jun 2025 | 20k | $61k |
| Catalyst Funds Management Pty | Jun 2025 | 12k | $37k |
| Ieq Capital | Jun 2025 | 11k | $34k |
| Axq Capital | Jun 2025 | 10k | $32k |
| Point72 | Jun 2025 | 1.7k | $5.2k |
| True Wealth Design | Jun 2025 | 220.00 | $675.994000 |
| Raymond James Financial | Jun 2025 | 189.00 | $567.000000 |